EDAN(SZ:300206) Cai Jing Wang·2026-01-20 07:50Core Viewpoint - The company expects a significant increase in net profit for the fiscal year 2025, driven by growth in overseas markets and specific business segments [1] Financial Performance - The projected net profit attributable to shareholders for 2025 is estimated to be between 284 million to 332 million yuan, representing a growth of 75.00% to 105.00% compared to the previous year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 273 million to 316 million yuan, with a growth range of 90.00% to 120.00% [1] Business Growth Drivers - The announcement highlights that the growth in performance is primarily due to steady progress in overseas markets and significant growth in patient monitoring and ultrasound imaging businesses [1] Non-Recurring Gains - The impact of non-recurring gains and losses on net profit is anticipated to be 14 million yuan, mainly from government subsidies, which is a decrease of 4 million yuan compared to the previous year [1]